14 results
8-K
EX-2.1
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
EX-2.1
AVTX
Avalo Therapeutics Inc
12 Sep 23
Avalo Enters into Agreement to Divest AVTX-800 Series
7:10am
8-K/A
EX-2.1
AVTX
Avalo Therapeutics Inc
10 Dec 19
Entry into a Material Definitive Agreement
9:38pm
425
EX-2.1
AVTX
Avalo Therapeutics Inc
10 Dec 19
Business combination disclosure
9:36pm
8-K
EX-2.1
AVTX
Avalo Therapeutics Inc
5 Dec 19
Cerecor to Acquire Aevi Genomic Medicine
4:21pm
425
EX-2.1
geduo2ih
5 Dec 19
Business combination disclosure
4:19pm
8-K
EX-2.1
03lzm
4 Nov 19
Cerecor Closes Deal to Sell Pediatric Portfolio
7:15am
8-K
EX-2.1
7rji4tq
15 Oct 19
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-2.1
34w9p5o4bls2yfmvnjf
26 Sep 18
Cerecor to Acquire Ichorion Therapeutics
12:00am
424B3
EX-2.1
lbndsj
11 May 18
Prospectus supplement
12:50pm
8-K
EX-2.1
mpc b3wt4gxjobk
17 Nov 17
Cerecor Acquires TRx Pharmaceuticals
12:00am
8-K
EX-2.2
veq46uy
17 Nov 17
Cerecor Acquires TRx Pharmaceuticals
12:00am
8-K
EX-2.1
64u69j0bzvd5rb qq
14 Aug 17
Cerecor Inc. Reports Second Quarter 2017 Financial Results
12:00am
- Prev
- 1
- Next